XIAP and cancer: Post‐transcriptional upregulation of XIAP by various mechanisms in conjunction with limited therapy response has been reported for multiple cancer entities (Tamm et al, 2000; Gu et al, 2009; Nishioka et al, 2016; Yang et al, 2017).